Your browser doesn't support javascript.
loading
Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically.
Giliberto, Mariaserena; Thimiri Govinda Raj, Deepak B; Cremaschi, Andrea; Skånland, Sigrid S; Gade, Alexandra; Tjønnfjord, Geir E; Schjesvold, Fredrik; Munthe, Ludvig A; Taskén, Kjetil.
Affiliation
  • Giliberto M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway.
  • Thimiri Govinda Raj DB; K.G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Cremaschi A; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Norway.
  • Skånland SS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway.
  • Gade A; K.G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Tjønnfjord GE; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Norway.
  • Schjesvold F; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Norway.
  • Munthe LA; Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Norway.
  • Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway.
Mol Oncol ; 16(6): 1241-1258, 2022 03.
Article in En | MEDLINE | ID: mdl-35148457
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Multiple Myeloma Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Mol Oncol Year: 2022 Type: Article Affiliation country: Norway
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Multiple Myeloma Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Mol Oncol Year: 2022 Type: Article Affiliation country: Norway